Miracor Medical is a European medical device company dedicated to improve clinical outcome of patients with impaired cardiac function.
The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
Miracor develops and studies the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack.
Recent Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients.
The company is conducting further clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting).
Miracor has won several innovation awards and completed financing rounds raising venture capital and public funding.
The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
Miracor develops and studies the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System consisting of a driving console and associated catheters for improving outcomes for severe heart attack patients. The Miracor PICSO Impulse System seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack.
Recent Clinical Studies have successfully demonstrated the positive effects of PICSO on infarct size reduction in acute heart attack patients.
The company is conducting further clinical trials to document the safety and effectiveness of the PICSO Impulse System in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention (PCI-stenting).
Miracor has won several innovation awards and completed financing rounds raising venture capital and public funding.
Location: Belgium, Liège
Employees: 11-50
Total raised: $119.79M
Founded date: 2008
Investors 9
Funding Rounds 7
| Date | Series | Amount | Investors |
| 02.09.2020 | - | $28.43M | - |
| 04.09.2018 | - | $34.76M | - |
| 04.01.2018 | Series D | $30.17M | - |
| 25.10.2016 | Series C | $7.62M | - |
| 08.01.2015 | Series B | $5.31M | - |
| 28.02.2012 | - | $3.5M | - |
| 14.09.2011 | Series B | $10M | - |
Mentions in press and media 20
| Date | Title | Description |
| 02.09.2020 | Miracor Medical Raises €24M in Funding | Miracor Medical SA, an Awans, Belgium-based provider of innovative solutions for the treatment of severe cardiac diseases, closed a €24M Series E round of financing. The round was led by a new corporate strategic investor joined by co-inves... |
| 05.09.2018 | Term Sheet — Wednesday, September 5 | 5 Qs WITH A DEALMAKER A venture firm called Hypothesis Ventures has formed to take advantage of a new $6 trillion opportunity — and that opportunity is found outside Silicon Valley. Paid Content Securing the enterprise without boundaries Fr... |
| 04.09.2018 | Miracor Medical Closes Final Tranche of Series D; Round Totals €30M | Miracor Medical SA, an Awans, Belgium-based provider of innovative solutions for the treatment of severe cardiac diseases, raised the final tranche of its Series D financing round, which was closed at €30M. The round was led by Ming Capital... |
| 04.01.2018 | Miracor Medical Systems Raises €25M in Series D Financing Round | Miracor Medical Systems, an Awans, Belgium-based medical device company developing innovative solutions to treat severe heart diseases, raised €25m in Series D financing round. The round – which includes equity and debt, as well as non-dilu... |
| 25.10.2016 | Miracor Medical Systems Raises €7M in Series C Financing | Miracor Medical Systems GmbH, a Vienna, Austria-based provider of innovative solutions for the treatment of severe cardiac diseases, has raised €7M in Series C financing round. The round is being led by Peppermint VenturePartners, who inves... |
| 15.09.2016 | ReFlow Therapeutics Closes Oversubscribed Seed Round | |
| 09.01.2015 | Miracor Medical Systems receives additional funding | |
| 08.01.2015 | Miracor Medical Systems Closes €4.5M Extension to Series B Financing | Miracor Medical Systems, a Vienna, Austria-based medical device company, closed a €4.5m extension to its Series B financing. Backers included new investors BioMedInvest and aws Gründerfonds and existing investors Earlybird Venture Capital, ... |
| 26.03.2013 | First German heart attack patient treated with Miracor product | |
| 18.02.2013 | Miracor granted six additional patents | Miracor Medical Systems GmbH announced today that 2012 was a record patent year with five new U.S. patents granted and an additional European patent protecting intellectual property related to its novel PICSO (Pressure-controlled Intermitte... |
Show more